blog

Agree or Disagree: Clinical Trial Sites Must Invest in Branding

By BBK Worldwide on Mon, Apr 30, 2018

There is a difference between “advertising” to generate referrals for clinical studies and “branding” for clinical trial sites. To remain relevant in a changing media landscape, sites must allocate part of their advertising budget to invest in branding. Do you agree? Disagree? Leave a comment below.

Topics: Pharma15

Agree or Disagree: Regulatory Bodies Need Social Media Training

By BBK Worldwide on Wed, Apr 25, 2018

If regulatory bodies are reviewing advertising and content for digital channels, like social media, should they receive education to understand how these channels work?

Check out the latest clip from our first Pharma15 Live! debate. Do you agree? Disagree? Leave a comment below.

Topics: clinical research, Social Media, Pharma15

Clinical Trial Advertising: Is It Just About Referrals?

By BBK Worldwide on Mon, Apr 23, 2018 | 1 min read

When it comes to direct-to-consumer advertising for clinical trials, is it just about generating referrals for sites? Or is the quality of the referral more important than quantity?

Watch this clip from our first Pharma15 Live! debate between industry experts. Do you agree or disagree? Comment below!

Topics: Pharma15

Watch On Demand: Experts Square Off on Clinical Trial Advertising

By BBK Worldwide on Fri, Mar 30, 2018 | 1 min read

Screen Shot 2018-03-30 at 3.45.36 PMJust last week, industry experts Matt Kibby, Shwen Gwee, and Dan Sfera squared off on a live 15-minute showdown, debating the timely topic of direct-to-consumer advertising to support clinical trial recruitment.

Moderated by Kaitlin Kelleher, conference producer at Cambridge Healthtech Institute, our challengers were tasked with debating many of the burning issues surrounding clinical trial advertising in today's shifting patient recruitment landscape.

We're excited to present the full debate for your viewing pleasure. And for those who were unable to catch the event live, we hope you enjoy it!

Topics: clinical trials, advertising, global patient recruitment, Pharma15

The Debate is Heating Up!

By Aaron Fleishman on Wed, Mar 21, 2018 | 2 min read

When it comes to clinical trial advertising, is “the juice worth the squeeze,” so to speak? To get at the heart of this issue, BBK Worldwide is bringing together industry experts to square off on the live video stream debate “Does Clinical Trial Advertising Deliver?” 

Join us on March 28th at 1:00pm EDT for a live 15-minute showdown between experts, debating the timely topic of direct-to-consumer advertising to support clinical trial recruitment.

With this lineup, you will not want to miss it!

Topics: global patient recruitment, clinical trials, Patient Recruitment, Pharma15

BBK to Attend SCOPE 2018 in Orlando

By BBK Worldwide on Thu, Feb 8, 2018 | 2 min read

mobile-header.jpgBBK Worldwide is very excited to be participating in the 9th Annual SCOPE Summit for Clinical Ops Executives. Taking place February 12 – 15 in Orlando FL, SCOPE will offer three days of in-depth discussions addressing the operational, technological and data-related aspects of clinical trial planning and management, with 18 different conferences, 3 plenary keynote sessions and interactive breakout discussions.

Topics: Conferences, life sciences, clinical research

Insights from Dr. Elliot Rosenstein: Referring Physicians in Clinical Trials

By BBK Worldwide on Wed, Jan 31, 2018 | 4 min read

 

For our latest eBook 21st Century Research Champions, we reached out to physicians to gain a deeper understanding about their attitudes and actions with regard to clinical research, and explored tested strategies in building relationships with physicians to enhance patient recuritment. As it turns out, physicians were more than happy to provide their insights into the value of referring physician programs and to elaborate on their willingness to contribute to clinical research. We interviwed Dr. Eliott Rosenstein -- a physician with more than 40 years of experience and Director of the Institute for Rheumatic and Autoimmune diseases -- to get his take on our latest eBook and the importance of referring physicians in clinical trial patient recruitment.

Topics: Physician Referrals, clinical research, clinical trials, Most Viewed

Gone Are 60 Seconds

By Matt Kibby on Thu, Jan 4, 2018 | 4 min read

Picture this: a clammy Nicolas Cage sits hunched forward in the driver’s seat of a $5m hypercar, gripping the top of the steering wheel and staring at an undefined point just beyond the camera.

His grip on the wheel tightens and he punches the accelerator.

In a cacophony of protesting rubber and tire smoke, he’s Gone in 60 Seconds.

Sound familiar? I’m making a tenuous but spellbinding opening remark to get our blood flowing about advertising. Not just advertising in general but also, more specifically, patient recruitment advertising. 

Topics: clinical research, advertising, Most Viewed

eConsent: A Patient-Centric Perspective

By BBK on Thu, Nov 30, 2017 | 2 min read

When patients find themselves interacting with information about their health and well-being, it is the responsibility of healthcare professionals to ensure that these interactions are as meaningful and productive as they can be. In this regard, the informed consent process is among the most important facets of clinical research currently undergoing a digital transformation, and pharmaceutical companies must continue to adopt eConsent across the board.

Topics: clinical trials, clinical research, digital health, Digital Platforms, informed consent

Sponsor of Choice

By Matt Kibby on Mon, Oct 30, 2017 | 2 min read

In an age where patients have more choice about treatment options (just think about how the treatment guidelines have evolved for multiple sclerosis or rheumatoid arthritis in the last 10 years for example,) and more clinical trials are being conducted by fewer investigators, there has been a constant upward pressure on competition for clinical trial patients, even as sponsors and third party recruitment companies becomes more innovative and proactive in their approaches to marketing their trials.

Topics: clinical trials, clinical research, Site Engagement, Patient Engagement

 
Subscribe To Our Blog